ARNUITY ELLIPTA
ARNUITY ELLIPTA
Approved
DIN Number
02446561
Drug Class
Human
Market Date
Jan 26, 2016
Company
HC
GlaxoSmithKline Inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02446561
AIG Number0152271002
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
R03BA09 FLUTICASONE FUROATE
Product Specifications
Dosage FormPowder
Route of AdministrationOral
,
Inhalation
AHFS Classification52:08.08
Health Canada Classification
ACTIVE INGREDIENTS (1)
FLUTICASONE FUROATEActive
Strength: 100 MCG / ACT
Monograph: FLUTICASONE FUROATE